Hence, in NSCLC, when ROS1 gene rearrangement (most often with CD74, SLC34A2, or FIG proteins) takes place, oncogenic hyperactivity of the protein is observed [130]. This evidence concerns the gene ROS1 and non-small cell lung carcinoma.